APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Pharma

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI Pharma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchAI Pharma Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Pharma Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal AI Pharma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Pharma Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Pharma Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global AI Pharma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI Pharma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI Pharma include Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrödinger, Lantern Pharma and XtalPi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI Pharma market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Pharma and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Pharma revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Pharma market size, projected growth trends, production technologies, key applications, and end-use industries.

AI Pharma Segment by Company

Recursion

Insilico Medicine

Exscientia

BenevolentAI

Atomwise

Roivant Sciences

Schrödinger

Lantern Pharma

XtalPi

Landos Biopharma

Relay Therapeutics

Accutar Biotech

Deep Genomics

Oncocross

AI Therapeutics

BioMap

METiS Pharmaceuticals

NeoX Biotech

StoneWise

Deep Intelligent Pharma

Gigaceuticals

Chemical.AI

Artivila

Galixir

Xbiome

AI Pharma Segment by Type

Self-developed Oipeline

Contract Research Organization (CRO)

Other

AI Pharma Segment by Application

Preclinical Stage (Optimization of Lead Compounds, etc.)

Clinical Trial Phase (Predicting Treatment Outcome, etc.)

AI Pharma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pharma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Pharma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pharma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Pharma in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Pharma industry.

Chapter 3: Detailed analysis of AI Pharma companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Pharmarevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Pharma Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Self-developed Oipeline Table 3. Key Players of Contract Research Organization (CRO) Table 4. Key Players of Other Table 4. Global AI Pharma Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Preclinical Stage (Optimization of Lead Compounds, etc.) Table 6. Key Players of Clinical Trial Phase (Predicting Treatment Outcome, etc.) Table 7. Global AI Pharma Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global AI Pharma Market Size by Region (2021-2026) & (US$ Million) Table 9. Global AI Pharma Market Share by Region (2021-2026) Table 10. Global AI Pharma Market Size by Region (2027-2032) & (US$ Million) Table 11. Global AI Pharma Market Share by Region (2027-2032) Table 12. AI Pharma Industry Trends Table 13. AI Pharma Industry Drivers Table 14. AI Pharma Industry Opportunities and Challenges Table 15. AI Pharma Industry Restraints Table 16. Global AI Pharma Revenue by Company (US$ Million) & (2021-2026) Table 17. Global AI Pharma Revenue Market Share by Company (2021-2026) Table 18. Global AI Pharma Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global AI Pharma Key Company Head Office and Area Served Table 20. Global AI Pharma Company, Product Type & Application Table 21. Global AI Pharma Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global AI Pharma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global AI Pharma Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global AI Pharma Market Size by Type (2021-2026) & (US$ Million) Table 26. Global AI Pharma Market Size by Type (2027-2032) & (US$ Million) Table 27. Global AI Pharma Revenue Market Share by Type (2021-2026) Table 28. Global AI Pharma Revenue Market Share by Type (2027-2032) Table 29. Global AI Pharma Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global AI Pharma Market Size by Application (2021-2026) & (US$ Million) Table 31. Global AI Pharma Market Size by Application (2027-2032) & (US$ Million) Table 32. Global AI Pharma Revenue Market Share by Application (2021-2026) Table 33. Global AI Pharma Revenue Market Share by Application (2027-2032) Table 34. Recursion Company Information Table 35. Recursion Business Overview Table 36. Recursion AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Recursion AI Pharma Product Portfolio Table 38. Recursion Recent Development Table 39. Insilico Medicine Company Information Table 40. Insilico Medicine Business Overview Table 41. Insilico Medicine AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Insilico Medicine AI Pharma Product Portfolio Table 43. Insilico Medicine Recent Development Table 44. Exscientia Company Information Table 45. Exscientia Business Overview Table 46. Exscientia AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Exscientia AI Pharma Product Portfolio Table 48. Exscientia Recent Development Table 49. BenevolentAI Company Information Table 50. BenevolentAI Business Overview Table 51. BenevolentAI AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. BenevolentAI AI Pharma Product Portfolio Table 53. BenevolentAI Recent Development Table 54. Atomwise Company Information Table 55. Atomwise Business Overview Table 56. Atomwise AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Atomwise AI Pharma Product Portfolio Table 58. Atomwise Recent Development Table 59. Roivant Sciences Company Information Table 60. Roivant Sciences Business Overview Table 61. Roivant Sciences AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Roivant Sciences AI Pharma Product Portfolio Table 63. Roivant Sciences Recent Development Table 64. Schrödinger Company Information Table 65. Schrödinger Business Overview Table 66. Schrödinger AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Schrödinger AI Pharma Product Portfolio Table 68. Schrödinger Recent Development Table 69. Lantern Pharma Company Information Table 70. Lantern Pharma Business Overview Table 71. Lantern Pharma AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Lantern Pharma AI Pharma Product Portfolio Table 73. Lantern Pharma Recent Development Table 74. XtalPi Company Information Table 75. XtalPi Business Overview Table 76. XtalPi AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. XtalPi AI Pharma Product Portfolio Table 78. XtalPi Recent Development Table 79. Landos Biopharma Company Information Table 80. Landos Biopharma Business Overview Table 81. Landos Biopharma AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Landos Biopharma AI Pharma Product Portfolio Table 83. Landos Biopharma Recent Development Table 84. Relay Therapeutics Company Information Table 85. Relay Therapeutics Business Overview Table 86. Relay Therapeutics AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Relay Therapeutics AI Pharma Product Portfolio Table 88. Relay Therapeutics Recent Development Table 89. Accutar Biotech Company Information Table 90. Accutar Biotech Business Overview Table 91. Accutar Biotech AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Accutar Biotech AI Pharma Product Portfolio Table 93. Accutar Biotech Recent Development Table 94. Deep Genomics Company Information Table 95. Deep Genomics Business Overview Table 96. Deep Genomics AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Deep Genomics AI Pharma Product Portfolio Table 98. Deep Genomics Recent Development Table 99. Oncocross Company Information Table 100. Oncocross Business Overview Table 101. Oncocross AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Oncocross AI Pharma Product Portfolio Table 103. Oncocross Recent Development Table 104. AI Therapeutics Company Information Table 105. AI Therapeutics Business Overview Table 106. AI Therapeutics AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. AI Therapeutics AI Pharma Product Portfolio Table 108. AI Therapeutics Recent Development Table 109. BioMap Company Information Table 110. BioMap Business Overview Table 111. BioMap AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. BioMap AI Pharma Product Portfolio Table 113. BioMap Recent Development Table 114. METiS Pharmaceuticals Company Information Table 115. METiS Pharmaceuticals Business Overview Table 116. METiS Pharmaceuticals AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. METiS Pharmaceuticals AI Pharma Product Portfolio Table 118. METiS Pharmaceuticals Recent Development Table 119. NeoX Biotech Company Information Table 120. NeoX Biotech Business Overview Table 121. NeoX Biotech AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. NeoX Biotech AI Pharma Product Portfolio Table 123. NeoX Biotech Recent Development Table 124. StoneWise Company Information Table 125. StoneWise Business Overview Table 126. StoneWise AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. StoneWise AI Pharma Product Portfolio Table 128. StoneWise Recent Development Table 129. Deep Intelligent Pharma Company Information Table 130. Deep Intelligent Pharma Business Overview Table 131. Deep Intelligent Pharma AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Deep Intelligent Pharma AI Pharma Product Portfolio Table 133. Deep Intelligent Pharma Recent Development Table 134. Gigaceuticals Company Information Table 135. Gigaceuticals Business Overview Table 136. Gigaceuticals AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 137. Gigaceuticals AI Pharma Product Portfolio Table 138. Gigaceuticals Recent Development Table 139. Chemical.AI Company Information Table 140. Chemical.AI Business Overview Table 141. Chemical.AI AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 142. Chemical.AI AI Pharma Product Portfolio Table 143. Chemical.AI Recent Development Table 144. Artivila Company Information Table 145. Artivila Business Overview Table 146. Artivila AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 147. Artivila AI Pharma Product Portfolio Table 148. Artivila Recent Development Table 149. Galixir Company Information Table 150. Galixir Business Overview Table 151. Galixir AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 152. Galixir AI Pharma Product Portfolio Table 153. Galixir Recent Development Table 154. Xbiome Company Information Table 155. Xbiome Business Overview Table 156. Xbiome AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026) Table 157. Xbiome AI Pharma Product Portfolio Table 158. Xbiome Recent Development Table 159. North America AI Pharma Market Size by Type (2021-2026) & (US$ Million) Table 160. North America AI Pharma Market Size by Type (2027-2032) & (US$ Million) Table 161. North America AI Pharma Market Size by Application (2021-2026) & (US$ Million) Table 162. North America AI Pharma Market Size by Application (2027-2032) & (US$ Million) Table 163. North America AI Pharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America AI Pharma Market Size by Country (2021-2026) Table 165. North America AI Pharma Market Size by Country (2027-2032) Table 166. Europe AI Pharma Market Size by Type (2021-2026) & (US$ Million) Table 167. Europe AI Pharma Market Size by Type (2027-2032) & (US$ Million) Table 168. Europe AI Pharma Market Size by Application (2021-2026) & (US$ Million) Table 169. Europe AI Pharma Market Size by Application (2027-2032) & (US$ Million) Table 170. Europe AI Pharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe AI Pharma Market Size by Country (2021-2026) Table 172. Europe AI Pharma Market Size by Country (2027-2032) Table 173. China AI Pharma Market Size by Type (2021-2026) & (US$ Million) Table 174. China AI Pharma Market Size by Type (2027-2032) & (US$ Million) Table 175. China AI Pharma Market Size by Application (2021-2026) & (US$ Million) Table 176. China AI Pharma Market Size by Application (2027-2032) & (US$ Million) Table 177. Asia AI Pharma Market Size by Type (2021-2026) & (US$ Million) Table 178. Asia AI Pharma Market Size by Type (2027-2032) & (US$ Million) Table 179. Asia AI Pharma Market Size by Application (2021-2026) & (US$ Million) Table 180. Asia AI Pharma Market Size by Application (2027-2032) & (US$ Million) Table 181. Asia AI Pharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Asia AI Pharma Market Size by Country (2021-2026) Table 183. Asia AI Pharma Market Size by Country (2027-2032) Table 184. South America, Middle East & Africa AI Pharma Market Size by Type (2021-2026) & (US$ Million) Table 185. South America, Middle East & Africa AI Pharma Market Size by Type (2027-2032) & (US$ Million) Table 186. South America, Middle East & Africa AI Pharma Market Size by Application (2021-2026) & (US$ Million) Table 187. South America, Middle East & Africa AI Pharma Market Size by Application (2027-2032) & (US$ Million) Table 188. South America, Middle East & Africa AI Pharma Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. South America, Middle East & Africa AI Pharma Market Size by Country (2021-2026) Table 190. South America, Middle East & Africa AI Pharma Market Size by Country (2027-2032) Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. AI Pharma Product Image Figure 2. Global AI Pharma Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI Pharma Market Share by Type: 2025 VS 2032 Figure 4. Self-developed Oipeline Image Figure 5. Contract Research Organization (CRO) Image Figure 6. Other Image Figure 7. Global AI Pharma Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global AI Pharma Market Share by Application: 2025 VS 2032 Figure 9. Preclinical Stage (Optimization of Lead Compounds, etc.) Image Figure 10. Clinical Trial Phase (Predicting Treatment Outcome, etc.) Image Figure 11. Global AI Pharma Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global AI Pharma Market Size (2021-2032) & (US$ Million) Figure 13. Global AI Pharma Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global AI Pharma Market Share by Players in 2025 Figure 16. Global Top 5 and 10 AI Pharma Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global AI Pharma Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global AI Pharma Revenue Market Share by Type (2021-2032) Figure 20. Global AI Pharma Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI Pharma Revenue Market Share by Application (2021-2032) Figure 22. North America AI Pharma Market Size (2021-2032) & (US$ Million) Figure 23. North America AI Pharma Market Share by Type (2021-2032) Figure 24. North America AI Pharma Market Share by Application (2021-2032) Figure 25. North America AI Pharma Market Share by Country (2021-2032) Figure 26. United States AI Pharma Market Size (2021-2032) & (US$ Million) Figure 27. Canada AI Pharma Market Size (2021-2032) & (US$ Million) Figure 28. Mexico AI Pharma Market Size (2021-2032) & (US$ Million) Figure 29. Europe AI Pharma Market Size (2021-2032) & (US$ Million) Figure 30. Europe AI Pharma Market Share by Type (2021-2032) Figure 31. Europe AI Pharma Market Share by Application (2021-2032) Figure 32. Europe AI Pharma Market Share by Country (2021-2032) Figure 33. Germany AI Pharma Market Size (2021-2032) & (US$ Million) Figure 34. France AI Pharma Market Size (2021-2032) & (US$ Million) Figure 35. U.K. AI Pharma Market Size (2021-2032) & (US$ Million) Figure 36. Italy AI Pharma Market Size (2021-2032) & (US$ Million) Figure 37. Russia AI Pharma Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries AI Pharma Market Size (2021-2032) & (US$ Million) Figure 39. China AI Pharma Market Size (2021-2032) & (US$ Million) Figure 40. China AI Pharma Market Share by Type (2021-2032) Figure 41. China AI Pharma Market Share by Application (2021-2032) Figure 42. Asia AI Pharma Market Size (2021-2032) & (US$ Million) Figure 43. Asia AI Pharma Market Share by Type (2021-2032) Figure 44. Asia AI Pharma Market Share by Application (2021-2032) Figure 45. Asia AI Pharma Market Share by Country (2021-2032) Figure 46. Japan AI Pharma Market Size (2021-2032) & (US$ Million) Figure 47. South Korea AI Pharma Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan AI Pharma Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia AI Pharma Market Size (2021-2032) & (US$ Million) Figure 50. India AI Pharma Market Size (2021-2032) & (US$ Million) Figure 51. Australia AI Pharma Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa AI Pharma Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa AI Pharma Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa AI Pharma Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa AI Pharma Market Share by Country (2021-2032) Figure 56. Brazil AI Pharma Market Size (2021-2032) & (US$ Million) Figure 57. South Africa AI Pharma Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia AI Pharma Market Size (2021-2032) & (US$ Million) Figure 59. Turkey AI Pharma Market Size (2021-2032) & (US$ Million) Figure 60. Argentina AI Pharma Market Size (2021-2032) & (US$ Million) Figure 61. UAE AI Pharma Market Size (2021-2032) & (US$ Million) Figure 62. Egypt AI Pharma Market Size (2021-2032) & (US$ Million) Figure 63. Chile AI Pharma Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Self-developed Oipeline
  • Contract Research Organization (CRO)
  • Other
Applications
  • Preclinical Stage (Optimization of Lead Compounds, etc.)
  • Clinical Trial Phase (Predicting Treatment Outcome, etc.)
Companies covered
  • Recursion
  • Insilico Medicine
  • Exscientia
  • BenevolentAI
  • Atomwise
  • Roivant Sciences
  • Schrödinger
  • Lantern Pharma
  • XtalPi
  • Landos Biopharma
  • Relay Therapeutics
  • Accutar Biotech
  • Deep Genomics
  • Oncocross
  • AI Therapeutics
  • BioMap
  • METiS Pharmaceuticals
  • NeoX Biotech
  • StoneWise
  • Deep Intelligent Pharma
  • Gigaceuticals
  • Chemical.AI
  • Artivila
  • Galixir
  • Xbiome

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI Pharma Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Self-developed Oipeline
  5. 1.2.3 Contract Research Organization (CRO)
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global AI Pharma Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
  10. 1.3.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global AI Pharma Growth Trends by Region
  13. 1.5.1 Global AI Pharma Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 AI Pharma Market Size by Region (2021-2026)
  15. 1.5.3 AI Pharma Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global AI Pharma Market Dynamics
  1. 2.1 AI Pharma Industry Trends
  2. 2.2 AI Pharma Industry Drivers
  3. 2.3 AI Pharma Industry Opportunities and Challenges
  4. 2.4 AI Pharma Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI Pharma Revenue by Company (2021-2026)
  2. 3.2 Global AI Pharma Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI Pharma Key Company Head office and Area Served
  4. 3.4 Global AI Pharma Company, Product Type & Application
  5. 3.5 Global AI Pharma Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI Pharma Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI Pharma Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI Pharma Tier 1, Tier 2, and Tier 3
4 AI Pharma Market by Type
  1. 4.1 Global AI Pharma Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI Pharma Market Size by Type (2021-2032)
  3. 4.3 Global AI Pharma Market Size Share by Type (2021-2032)
5 AI Pharma Market by Application
  1. 5.1 Global AI Pharma Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Pharma Market Size by Application (2021-2032)
  3. 5.3 Global AI Pharma Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Recursion
  2. 6.1.1 Recursion Company Information
  3. 6.1.2 Recursion Business Overview
  4. 6.1.3 Recursion AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Recursion AI Pharma Product Portfolio
  6. 6.1.5 Recursion Recent Developments
  7. 6.2 Insilico Medicine
  8. 6.2.1 Insilico Medicine Company Information
  9. 6.2.2 Insilico Medicine Business Overview
  10. 6.2.3 Insilico Medicine AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Insilico Medicine AI Pharma Product Portfolio
  12. 6.2.5 Insilico Medicine Recent Developments
  13. 6.3 Exscientia
  14. 6.3.1 Exscientia Company Information
  15. 6.3.2 Exscientia Business Overview
  16. 6.3.3 Exscientia AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Exscientia AI Pharma Product Portfolio
  18. 6.3.5 Exscientia Recent Developments
  19. 6.4 BenevolentAI
  20. 6.4.1 BenevolentAI Company Information
  21. 6.4.2 BenevolentAI Business Overview
  22. 6.4.3 BenevolentAI AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BenevolentAI AI Pharma Product Portfolio
  24. 6.4.5 BenevolentAI Recent Developments
  25. 6.5 Atomwise
  26. 6.5.1 Atomwise Company Information
  27. 6.5.2 Atomwise Business Overview
  28. 6.5.3 Atomwise AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Atomwise AI Pharma Product Portfolio
  30. 6.5.5 Atomwise Recent Developments
  31. 6.6 Roivant Sciences
  32. 6.6.1 Roivant Sciences Company Information
  33. 6.6.2 Roivant Sciences Business Overview
  34. 6.6.3 Roivant Sciences AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Roivant Sciences AI Pharma Product Portfolio
  36. 6.6.5 Roivant Sciences Recent Developments
  37. 6.7 Schrödinger
  38. 6.7.1 Schrödinger Company Information
  39. 6.7.2 Schrödinger Business Overview
  40. 6.7.3 Schrödinger AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Schrödinger AI Pharma Product Portfolio
  42. 6.7.5 Schrödinger Recent Developments
  43. 6.8 Lantern Pharma
  44. 6.8.1 Lantern Pharma Company Information
  45. 6.8.2 Lantern Pharma Business Overview
  46. 6.8.3 Lantern Pharma AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Lantern Pharma AI Pharma Product Portfolio
  48. 6.8.5 Lantern Pharma Recent Developments
  49. 6.9 XtalPi
  50. 6.9.1 XtalPi Company Information
  51. 6.9.2 XtalPi Business Overview
  52. 6.9.3 XtalPi AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 XtalPi AI Pharma Product Portfolio
  54. 6.9.5 XtalPi Recent Developments
  55. 6.10 Landos Biopharma
  56. 6.10.1 Landos Biopharma Company Information
  57. 6.10.2 Landos Biopharma Business Overview
  58. 6.10.3 Landos Biopharma AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Landos Biopharma AI Pharma Product Portfolio
  60. 6.10.5 Landos Biopharma Recent Developments
  61. 6.11 Relay Therapeutics
  62. 6.11.1 Relay Therapeutics Company Information
  63. 6.11.2 Relay Therapeutics Business Overview
  64. 6.11.3 Relay Therapeutics AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Relay Therapeutics AI Pharma Product Portfolio
  66. 6.11.5 Relay Therapeutics Recent Developments
  67. 6.12 Accutar Biotech
  68. 6.12.1 Accutar Biotech Company Information
  69. 6.12.2 Accutar Biotech Business Overview
  70. 6.12.3 Accutar Biotech AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Accutar Biotech AI Pharma Product Portfolio
  72. 6.12.5 Accutar Biotech Recent Developments
  73. 6.13 Deep Genomics
  74. 6.13.1 Deep Genomics Company Information
  75. 6.13.2 Deep Genomics Business Overview
  76. 6.13.3 Deep Genomics AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Deep Genomics AI Pharma Product Portfolio
  78. 6.13.5 Deep Genomics Recent Developments
  79. 6.14 Oncocross
  80. 6.14.1 Oncocross Company Information
  81. 6.14.2 Oncocross Business Overview
  82. 6.14.3 Oncocross AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Oncocross AI Pharma Product Portfolio
  84. 6.14.5 Oncocross Recent Developments
  85. 6.15 AI Therapeutics
  86. 6.15.1 AI Therapeutics Company Information
  87. 6.15.2 AI Therapeutics Business Overview
  88. 6.15.3 AI Therapeutics AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 AI Therapeutics AI Pharma Product Portfolio
  90. 6.15.5 AI Therapeutics Recent Developments
  91. 6.16 BioMap
  92. 6.16.1 BioMap Company Information
  93. 6.16.2 BioMap Business Overview
  94. 6.16.3 BioMap AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 BioMap AI Pharma Product Portfolio
  96. 6.16.5 BioMap Recent Developments
  97. 6.17 METiS Pharmaceuticals
  98. 6.17.1 METiS Pharmaceuticals Company Information
  99. 6.17.2 METiS Pharmaceuticals Business Overview
  100. 6.17.3 METiS Pharmaceuticals AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 METiS Pharmaceuticals AI Pharma Product Portfolio
  102. 6.17.5 METiS Pharmaceuticals Recent Developments
  103. 6.18 NeoX Biotech
  104. 6.18.1 NeoX Biotech Company Information
  105. 6.18.2 NeoX Biotech Business Overview
  106. 6.18.3 NeoX Biotech AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 NeoX Biotech AI Pharma Product Portfolio
  108. 6.18.5 NeoX Biotech Recent Developments
  109. 6.19 StoneWise
  110. 6.19.1 StoneWise Company Information
  111. 6.19.2 StoneWise Business Overview
  112. 6.19.3 StoneWise AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 StoneWise AI Pharma Product Portfolio
  114. 6.19.5 StoneWise Recent Developments
  115. 6.20 Deep Intelligent Pharma
  116. 6.20.1 Deep Intelligent Pharma Company Information
  117. 6.20.2 Deep Intelligent Pharma Business Overview
  118. 6.20.3 Deep Intelligent Pharma AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Deep Intelligent Pharma AI Pharma Product Portfolio
  120. 6.20.5 Deep Intelligent Pharma Recent Developments
  121. 6.21 Gigaceuticals
  122. 6.21.1 Gigaceuticals Company Information
  123. 6.21.2 Gigaceuticals Business Overview
  124. 6.21.3 Gigaceuticals AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Gigaceuticals AI Pharma Product Portfolio
  126. 6.21.5 Gigaceuticals Recent Developments
  127. 6.22 Chemical.AI
  128. 6.22.1 Chemical.AI Company Information
  129. 6.22.2 Chemical.AI Business Overview
  130. 6.22.3 Chemical.AI AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Chemical.AI AI Pharma Product Portfolio
  132. 6.22.5 Chemical.AI Recent Developments
  133. 6.23 Artivila
  134. 6.23.1 Artivila Company Information
  135. 6.23.2 Artivila Business Overview
  136. 6.23.3 Artivila AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Artivila AI Pharma Product Portfolio
  138. 6.23.5 Artivila Recent Developments
  139. 6.24 Galixir
  140. 6.24.1 Galixir Company Information
  141. 6.24.2 Galixir Business Overview
  142. 6.24.3 Galixir AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Galixir AI Pharma Product Portfolio
  144. 6.24.5 Galixir Recent Developments
  145. 6.25 Xbiome
  146. 6.25.1 Xbiome Company Information
  147. 6.25.2 Xbiome Business Overview
  148. 6.25.3 Xbiome AI Pharma Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Xbiome AI Pharma Product Portfolio
  150. 6.25.5 Xbiome Recent Developments
7 North America
  1. 7.1 North America AI Pharma Market Size (2021-2032)
  2. 7.2 North America AI Pharma Market Size by Type
  3. 7.2.1 North America AI Pharma Market Size by Type (2021-2026)
  4. 7.2.2 North America AI Pharma Market Size by Type (2027-2032)
  5. 7.2.3 North America AI Pharma Market Share by Type (2021-2032)
  6. 7.3 North America AI Pharma Market Size by Application
  7. 7.3.1 North America AI Pharma Market Size by Application (2021-2026)
  8. 7.3.2 North America AI Pharma Market Size by Application (2027-2032)
  9. 7.3.3 North America AI Pharma Market Share by Application (2021-2032)
  10. 7.4 North America AI Pharma Market Size by Country
  11. 7.4.1 North America AI Pharma Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI Pharma Market Size by Country (2021-2026)
  13. 7.4.3 North America AI Pharma Market Size by Country (2027-2032)
  14. 7.4.4 North America AI Pharma Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI Pharma Market Size (2021-2032)
  2. 8.2 Europe AI Pharma Market Size by Type
  3. 8.2.1 Europe AI Pharma Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI Pharma Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI Pharma Market Share by Type (2021-2032)
  6. 8.3 Europe AI Pharma Market Size by Application
  7. 8.3.1 Europe AI Pharma Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI Pharma Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI Pharma Market Share by Application (2021-2032)
  10. 8.4 Europe AI Pharma Market Size by Country
  11. 8.4.1 Europe AI Pharma Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI Pharma Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI Pharma Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI Pharma Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI Pharma Market Size (2021-2032)
  2. 9.2 China AI Pharma Market Size by Type
  3. 9.2.1 China AI Pharma Market Size by Type (2021-2026)
  4. 9.2.2 China AI Pharma Market Size by Type (2027-2032)
  5. 9.2.3 China AI Pharma Market Share by Type (2021-2032)
  6. 9.3 China AI Pharma Market Size by Application
  7. 9.3.1 China AI Pharma Market Size by Application (2021-2026)
  8. 9.3.2 China AI Pharma Market Size by Application (2027-2032)
  9. 9.3.3 China AI Pharma Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI Pharma Market Size (2021-2032)
  2. 10.2 Asia AI Pharma Market Size by Type
  3. 10.2.1 Asia AI Pharma Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI Pharma Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI Pharma Market Share by Type (2021-2032)
  6. 10.3 Asia AI Pharma Market Size by Application
  7. 10.3.1 Asia AI Pharma Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI Pharma Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI Pharma Market Share by Application (2021-2032)
  10. 10.4 Asia AI Pharma Market Size by Country
  11. 10.4.1 Asia AI Pharma Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI Pharma Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI Pharma Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI Pharma Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI Pharma Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI Pharma Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI Pharma Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI Pharma Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI Pharma Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI Pharma Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI Pharma Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI Pharma Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI Pharma Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI Pharma Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI Pharma Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI Pharma Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI Pharma Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI Pharma Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst